BY SCIENCE DAILY: New research links outdoor air pollution — even at levels deemed safe — to an increased risk of diabetes globally, according to a study from Washington University School of Medicine in St. Louis and the Veterans Affairs (VA) St. Louis Health Care System.
BY MATT HOFFMAN: Tim Dunn, PhD, the director of clinical and computational research at Abbott Diabetes Care, sat with MD Magat the American Diabetes Association’s 78th Annual Scientific Session to discuss the benefits the Freestyle Libre continuous glucose monitoring system (CGM) provides for both the patients and providers.
The system, approved by the US Food and Drug Administration in September 2017, reduces the requirement of “fingerstick” testing, where patients with diabetes would be required to prick their fingers to gather a blood glucose sample. The system uses a small sensor wire that is inserted below the surface of the skin and continuously monitors and measures levels. (read more)
BY ROBERT PREIDT: Human insulin is as safe and effective as newer, more expensive insulin analog drugs for people with type 2 diabetes, researchers report.
The new study included people with type 2 diabetes who were followed for an average of 1.7 years after they started using insulin.
“We found that for patients with type 2 diabetes in usual practice, the use of the more expensive insulin analogs did not appear to result in better safety — at least as defined by hospital or emergency visits for hypoglycemia — or better blood sugar control,” said lead author Dr. Kasia Lipska. She is an assistant professor of medicine at Yale School of Medicine. (read more)
BY NEWS-MEDICAL: Self-monitoring of type 2 diabetes used in combination with an electronic feedback system results in considerable savings on health care costs especially in sparsely populated areas, a new study from the University of Eastern Finland shows.
Self-monitoring delivers considerable savings on the overall costs of type 2 diabetes care, as well as on patients’ travel costs. Glycated hemoglobin testing is an important part of managing diabetes, and also a considerable cost item. By replacing half of the required follow-up visits with self-measurements and electronic feedback, the annual total costs of glycated hemoglobin monitoring were reduced by nearly 60 percent, bringing the per-patient cost down from 280 EUR (300 USD) to 120 EUR (130 USD). (read more)
BY JACK WOODFIELD: Pioneering artificial intelligence (AI) and radar technology has been shown to help people with diabetes manage their blood sugar levels.
The technology uses high-frequency radio waves to monitor blood sugar levels without the need for finger pricking. In a study by the University of Waterloo, the technology was 85% accurate in detecting glucose changes.
This innovative approach could potentially transform how millions of people monitor their blood sugar levels in the future.
The radar device was developed by Google and German hardware company Infineon. It works by sending frequency waves into liquids that contain different levels of glucose. The radio waves then reflect back to the radar device where the data is converted into digital data. This is then analysed using AI technology. (read more)